Related Experiment Video
Updated: Jun 20, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
Pain in Parkinson's disease.
Grace Helena Letro1, Elizabeth M A B Quagliato, Maura Aparecida Viana
1Neurology Department, Faculty of Medical Science, University of Campinas, Campinas, SP, Brazil. gletro@terra.com.br
Arquivos De Neuro-Psiquiatria
|September 2, 2009
Summary
Pain is common in Parkinson's disease (PD), often linked to the "off" period and stiffness. Levodopa treatment showed improvement in pain for over half of the patients studied.
Area of Science:
- Neurology
- Pain Management
- Movement Disorders
Background:
- Pain is a frequent, yet often overlooked, non-motor symptom in Parkinson's disease (PD).
- Understanding the characteristics and potential causes of pain in PD is crucial for improving patient quality of life.
Purpose of the Study:
- To investigate the prevalence and characteristics of pain in a cohort of Parkinson's disease patients.
- To explore the relationship between pain and disease severity, motor fluctuations, depression, and dyskinesia.
- To assess the impact of levodopa treatment on pain symptoms.
Main Methods:
- A cross-sectional study involving 50 patients (20 female, 30 male) diagnosed with Parkinson's disease.
- Utilized the Unified Parkinson's Disease Rating Scale (UPDRS), McGill Pain Questionnaire, and Beck Depression Inventory.
- Excluded participants with co-morbidities that could cause pain.
Main Results:
- Pain was associated with Parkinson's disease in 54% of patients.
- Pain occurred more frequently during the "off" period (44%) and was linked to stiffness.
- No significant association was found between pain and tremor, Modified Hoehn and Yahr stage, Schwab and England scale, depression, or dyskinesia.
- Levodopa treatment led to pain improvement in 59.26% of patients experiencing pain.
Conclusions:
- Pain is a prevalent symptom in Parkinson's disease, particularly during motor fluctuations (off periods) and associated with stiffness.
- Pain in PD does not appear to be directly correlated with tremor, disease severity, depression, or dyskinesia.
- Levodopa therapy demonstrates potential efficacy in alleviating pain symptoms in Parkinson's disease patients.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.